These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 31194940)
21. Structure-Based Design of a Soluble Prefusion-Closed HIV-1 Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity. Chuang GY; Geng H; Pancera M; Xu K; Cheng C; Acharya P; Chambers M; Druz A; Tsybovsky Y; Wanninger TG; Yang Y; Doria-Rose NA; Georgiev IS; Gorman J; Joyce MG; O'Dell S; Zhou T; McDermott AB; Mascola JR; Kwong PD J Virol; 2017 May; 91(10):. PubMed ID: 28275193 [TBL] [Abstract][Full Text] [Related]
22. A Rare Mutation in an Infant-Derived HIV-1 Envelope Glycoprotein Alters Interprotomer Stability and Susceptibility to Broadly Neutralizing Antibodies Targeting the Trimer Apex. Mishra N; Sharma S; Dobhal A; Kumar S; Chawla H; Singh R; Das BK; Kabra SK; Lodha R; Luthra K J Virol; 2020 Sep; 94(19):. PubMed ID: 32669335 [TBL] [Abstract][Full Text] [Related]
23. The Glycan Hole Area of HIV-1 Envelope Trimers Contributes Prominently to the Induction of Autologous Neutralization. Schorcht A; Cottrell CA; Pugach P; Ringe RP; Han AX; Allen JD; van den Kerkhof TLGM; Seabright GE; Schermer EE; Ketas TJ; Burger JA; van Schooten J; LaBranche CC; Ozorowski G; de Val N; Bader DLV; Schuitemaker H; Russell CA; Montefiori DC; van Gils MJ; Crispin M; Klasse PJ; Ward AB; Moore JP; Sanders RW J Virol; 2022 Jan; 96(1):e0155221. PubMed ID: 34669426 [TBL] [Abstract][Full Text] [Related]
35. Conformational States of a Soluble, Uncleaved HIV-1 Envelope Trimer. Liu Y; Pan J; Cai Y; Grigorieff N; Harrison SC; Chen B J Virol; 2017 May; 91(10):. PubMed ID: 28250125 [TBL] [Abstract][Full Text] [Related]
36. Asymmetric Structures and Conformational Plasticity of the Uncleaved Full-Length Human Immunodeficiency Virus Envelope Glycoprotein Trimer. Zhang S; Wang K; Wang WL; Nguyen HT; Chen S; Lu M; Go EP; Ding H; Steinbock RT; Desaire H; Kappes JC; Sodroski J; Mao Y J Virol; 2021 Nov; 95(24):e0052921. PubMed ID: 34549974 [TBL] [Abstract][Full Text] [Related]
37. Complete functional mapping of infection- and vaccine-elicited antibodies against the fusion peptide of HIV. Dingens AS; Acharya P; Haddox HK; Rawi R; Xu K; Chuang GY; Wei H; Zhang B; Mascola JR; Carragher B; Potter CS; Overbaugh J; Kwong PD; Bloom JD PLoS Pathog; 2018 Jul; 14(7):e1007159. PubMed ID: 29975771 [TBL] [Abstract][Full Text] [Related]
38. Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan. Liang Y; Guttman M; Williams JA; Verkerke H; Alvarado D; Hu SL; Lee KK J Virol; 2016 Oct; 90(20):9224-36. PubMed ID: 27489265 [TBL] [Abstract][Full Text] [Related]
39. An HIV-1 Broadly Neutralizing Antibody from a Clade C-Infected Pediatric Elite Neutralizer Potently Neutralizes the Contemporaneous and Autologous Evolving Viruses. Kumar S; Panda H; Makhdoomi MA; Mishra N; Safdari HA; Chawla H; Aggarwal H; Reddy ES; Lodha R; Kumar Kabra S; Chandele A; Dutta S; Luthra K J Virol; 2019 Feb; 93(4):. PubMed ID: 30429339 [TBL] [Abstract][Full Text] [Related]
40. X-ray and EM structures of a natively glycosylated HIV-1 envelope trimer. Gristick HB; Wang H; Bjorkman PJ Acta Crystallogr D Struct Biol; 2017 Oct; 73(Pt 10):822-828. PubMed ID: 28994411 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]